title: Leukocytoclastic vasculitis: A rare adverse effect secondary to infliximab.
authors.forename: Sami
authors.initials: S
authors.lastname: Karoui
authors.forename: Norsaf
authors.initials: N
authors.lastname: Bibani
authors.forename: Imed
authors.initials: I
authors.lastname: Ben Gorbel
authors.forename: Meriem
authors.initials: M
authors.lastname: Serghini
authors.forename: Mouna
authors.initials: M
authors.lastname: Mlika
authors.forename: Amel
authors.initials: A
authors.lastname: Braham
authors.forename: Ines
authors.initials: I
authors.lastname: Chelly
authors.forename: Slim
authors.initials: S
authors.lastname: Haouet
authors.forename: Habib
authors.initials: H
authors.lastname: Houmène
authors.forename: Azza
authors.initials: A
authors.lastname: Filali
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab